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ABSTRACT
Background: The skin prick test (SPT) for detecting atopic sensitization is not preferred in young infants with
atopic dermatitis (AD) because of concerns about poor skin reactivity. This study aimed to evaluate whether the
results of SPT agreed well with those of specific serum immunoglobulin E (sIgE) antibody test in young infants
with AD.
Methods: This study included 2,077 eligible infants (age, <12 months) with AD who were tested by either SPT
or sIgE between 2007 and 2011. Among them, 199 infants tested for egg white (EW) and 192 infants tested for
cow’s milk (CM), by both SPT and sIgE on the same day were identified and reviewed retrospectively. Kappa
statistics and tests for equal kappa statistics were used to evaluate the agreement between the SPT and sIgE.
Results: The mean wheal diameter and the allergen-to-histamine ratio of SPT showed substantial agreement
with those of sIgE for EW (κ = 0.62, 0.69) and CM (κ = 0.34, 0.47). The agreement for EW was significantly
higher <6-month-old than in6-month-old infants (κ = 0.79 vs. 0.54, P = 0.02), and that for CM was similar (P =
0.60). The mean wheal diameters for EW and CM were evenly distributed, and did not show increasing trends
regardless of age in months (Ptrend = 0.13 and 0.06, respectively).
Conclusions: The results of SPT agreed well with those of sIgE. This finding provides a rationale for using
SPT, and suggests that SPT can be used along with sIgE to detect food sensitization in young infants with AD.
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INTRODUCTION
Atopic dermatitis (AD) is one of the most common
chronic, recurrent, allergic skin disease in childhood,
with a prevalence of 10%-20% worldwide.1 A previous
study reported that 45% of children develop AD dur-
ing the first 6 months of life and approximately 60%
show symptoms within the first year of life.2
Recent evidence from longitudinal birth cohorts
has consistently indicated that either AD or atopic
sensitization during early life appears to be one of the
key predictors of later asthma or allergic rhinocon-
junctivitis.3,4 Moreover, atopic eczema with sensitiza-
tion (e.g., hen’s egg allergy), rather than non-atopic
eczema, during early life appears to have higher risk
of progressing to later asthma.4-6 Therefore, detection
of atopic sensitization is an important initial workup
for infants with AD, in both clinical and research set-
tings.
Allergen-specific serum immunoglobulin E (sIgE)
and the skin prick test (SPT) were accepted as the
first step for detecting the presence of IgE antibody
Allergology International. 2014;63:235-242
ORIGINAL ARTICLE
1Department of Pediatrics, Pediatric Allergy and Respiratory Cen-
ter, Soonchunhyang University Hospital, Soonchunhyang Univer-
sity College of Medicine, 3Biostatistical Consulting Unit, Soon-
chunhyang University Medical Center, Seoul and 2Department of
Pediatrics, Dongtan Sacred Heart Hospital, Hallym University Col-
lege of Medicine, Hwaseong, Korea.
Conflict of interest: No potential conflict of interest was disclosed.
Correspondence: Bok Yang Pyun, MD, PhD, Department of Pedi-
atrics, Pediatric Allergy and Respiratory Center, Soonchunhyang
University Hospital, Soonchunhyang University College of Medi-
cine, 22 Daesagwan-gil, Yongsan-gu, Seoul, 140−743, Korea.
Email: bypyun@schmc.ac.kr
Received 9 June 2013. Accepted for publication 12 December
2013.
2014 Japanese Society of Allergology
DOI: 10.2332allergolint.13-OA-0593
Yang HJ et al.
236 Allergology International Vol 63, No2, 2014 www.jsaweb.jp
in the diagnostic workup for AD or suspected food al-
lergy.7 SPT has been widely used to confirm or ex-
clude atopic sensitization and has many advantages in
clinical practice: (1) it is easy to perform, (2) it pro-
vides fast results, and (3) it is inexpensive.7 Neverthe-
less, SPT does not seem to be preferred in infants be-
cause of concerns that their skin response to allergen
might be poorer than that in older children, due to
the immaturity of their skin mast cells.8,9 However,
mast cells are not only potent effector cells in allergy
but also important players in the process of sensitiza-
tion to allergens,10 Moreover, skin exposure as well
as oral intake of causative food could may lead to con-
siderable IgE-mediated reaction even in early infancy.
It is therefore theoretically possible to perform skin
tests to detect relevant food sensitization even in
young infants.11 Although, good agreement between
SPT and sIgE for aeroallergens was consistently re-
ported,12,13 that for food allergens is still under de-
bate,14,15 and has not been fully evaluated, particular
in young infants with AD.
We hypothesized that the skin of young infants
with AD is sufficiently mature to react with allergens.
Therefore, the skin response to SPT will be sufficient
to detect atopic sensitization and will agree well with
the results of sIgE. To test this hypothesis, we con-
ducted a retrospective study on young infants with
AD.
The aims of this study were to evaluate: (1)
whether the results of SPT for food allergens agree
well with those of sIgE, and (2) whether the wheal re-
sponse of SPT is mature to detect atopic sensitization
in young infants with AD.
METHODS
STUDY DESIGN AND SETTING
Subjects included in this study were young infants
(age, <12 months) with AD who were referred to the
Pediatric Allergy and Respiratory Center, Soon-
chunhyang University Hospital (a tertiary medical
center in Seoul, Korea) from January 1, 2007 through
December 31, 2011.
This study was designed to evaluate the agreement
between SPT and sIgE in detecting food sensitization,
and the distribution of wheal responses according to
age in months in young infants with AD, retrospec-
tively. We comprehensively reviewed medical re-
cords, demographic data, and results of SPT and sIgE
of all subjects by using electronic and paper charts.
This study protocol was approved by the Soon-
chunhyang University Hospital Research Ethics Com-
mittee (J2012-145). The written consent requirement
was waived.
STUDY SUBJECTS
All subjects with AD were identified from electronic
medical records of our institute, using the Interna-
tional Classification of Diseases 9 code. A total of
2,878 infants (age, <12 months) with mild-to-
moderate AD graded by the SCORAD index16 were
identified. The medical records of 2,077 infants with
AD who underwent either SPT or sIgE for egg white
(EW) and cow’s milk (CM) were reviewed by the pri-
mary investigator. Among these 2,077 eligible infants,
we identified 233 infants tested for EW and 225 in-
fants tested for CM, who were evaluated by both SPT
and sIgE at the same date. The detailed subject inclu-
sion process is summarized in Figure 1. The exclu-
sion criteria were as follows: wheal diameter for hista-
mine <1 mm or saline1 mm. Subjects who exhibited
dermographism (n = 1) and histamine reactivity <1
mm (n = 33) to EW, and dermographism (n = 1) and
histamine reactivity <1 mm (n = 32) to CM were ex-
cluded.
DATA COLLECTION
The results of SPT and sIgE, which were performed
at the same date, were collected from the database
and reviewed by the primary investigator. In this
study, sIgE was measured using Pharmacia CAP
System FEIA (Pharmacia & Upjohn Diagnostics,
Uppsala, Sweden). SPT was performed by a trained
and experienced nurse by using commercial allergen
extracts (Allergopharma, Reinbek, Germany) accord-
ing to the standard technique.17 Briefly, a single drop
of allergen extracts was applied to the pricked (using
a standardized lancet) normal skin on the dorsal sur-
face of the upper back. Saline was used as a negative
control, and histamine (1 mgmL) was used as a posi-
tive control. Wheal and flare reactions were read at 15
min after the test. SPT was not performed on patients
with history of systemic reactions or those who anti-
histamines were administered within the last 4
weeks. We collected data on reported systemic ad-
verse reactions, such as angioedema or anaphylaxis.
DIAGNOSTIC DECISION POINT
In the SPT, food sensitization was defined when the
mean wheal diameter was 3 mm larger than that of
the negative control. Besides the mean wheal diame-
ter, we also calculated the allergen-to-histamine ratio
(AH). An AH ratio of1 was defined as positive.
Food sensitization was defined as sIgE level 0.35
kUL which is a positive cutoff value recommended
by the manufacturer.
STATISTICAL ANALYSIS
The distributions of demographic characteristics,
laboratory results, and mean wheal diameter in SPT
and sIgE according to age groups (ages, <6 and 6
months) were analyzed using the χ2-test or Fisher’s
exact test for categorical variables and by the Mann
Whitney U test for continuous variables, as appropri-
ate. As a measure of agreement between SPT and
SIgE, kappa statistics were calculated. Tests for equal
kappa statistics were used to compare kappa statistics
Agreement between SPT and Specific IgE
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Fig.　1　Flow chart depicting the selection of study subjects.
Assessed for eligibility (n = 2878)
Infants with mild to moderate atopic
dermatitis
Both SPT & sIgE on the same date
Egg white, n = 233
Cow milk, n = 225
Either SPT or sIgE (n = 2077)
Excluded:
SPT and sIgE on different date
Egg white, n = 1844
Cow milk, n = 1852
Excluded:
Egg white
Dermographism (n = 1)
Histamine reactivity <1 mm (n = 33)
Cow milk
Dermographism (n = 1)
Histamine reactivity <1 mm (n = 32) 
Analyzed
Egg white (n = 199)
Cow milk (n = 192)
between the 2 age groups (ages, <6 and 6 months).
A restricted cubic spline graph was used to estimate
the increasing trends of the mean wheal diameter for
EW and CM according to age in months. We also es-
timated the correlation between the mean wheal size
for food allergens and age in months. If data were
normally distributed, we calculated Pearson correla-
tion statistics for continuous variables. Otherwise,
Spearman correlation statistics were calculated. All
statistical analyses were performed with SAS software
version 9.3 (SAS Institute Inc., Cary, NC, USA). A P
value of <0.05 was considered the minimum level of
statistical significance. All hypothesis tests were 2-
sided.
RESULTS
STUDY POPULATION
Complete test results of SPT and sIgE were available
for EW in 199 infants and for CM in 199 infants. No
systemic adverse reactions were observed in only
subjects tested for EW or CM.
EGGWHITE
Of the 199 infants, 60 (30.2%) were aged <6 months.
The sensitization rates were 40.2% (80 of 199) in SPT,
54.8% (109 of 199) in sIgE, and 57.3% (114 of 199) in
either SPT or sIgE. The median wheal diameters for
histamine were not different significantly between the
2 age groups (P = 0.46), whereas those for EW were
greater in infants aged6 months (P < 0.05).
COWMILK
Of the 192 infants, 61 (31.8%) were aged <6 months.
The sensitization rates were 17.7% (34 of 192) in SPT,
38.5% (74 of 192) in sIgE, and 42.2% (81 of 192) in
either SPT or sIgE. The median wheal diameters for
histamine were not significantly different between the
2 age groups (P = 0.19), whereas those for CM were
greater in infants aged 6 months (P = 0.02) (Table
1).
AGREEMENT BETWEEN MEAN WHEAL DIAME-
TER OF SPT AND sIgE
As to EW, 68.8% for sensitivity, 94.4% for specificity,
93.8% for positive predictive value, and 71.4% for nega-
tive predictive value were observed between SPT and
sIgE. As to CW, 36.5% for sensitivity, 94.1% for speci-
ficity, 79.4% for positive predictive value, and 70.3% for
negative predictive value were observed. Substantial
agreement was observed as to EW (κ = 0.62),
whereas fair agreement was observed as to CM (κ =
0.34).
As to EW, the kappa value was significantly higher
in the age group of <6 months than in the age group
of 6 months (κ = 0.79 vs. 0.54, P = 0.02), while that
for CM was not different (κ = 0.26 versus 0.35, P =
0.60) (Table 2).
AGREEMENT BETWEEN THE AH RATIO AND
sIgE
As to EW, 77.1% for sensitivity, 93.3% for specificity,
93.3% for positive predictive value, and 77.1% for nega-
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Table　1　Characteristics of the study subjects tested by both SPT and sIgE for egg white (n = 199) and cow’s milk (n = 192)
Egg white Cow milk
Total
n = 199
<6 mo
n = 60
≥6 mo
n = 139 P
Total
n = 192
<6 mo
n = 61
≥6 mo
n = 131 P
Age, mo 7.0 
(5.0-9.0)
4.0 
(3.25-5.0)
8.0 
(7.0-10.0)
7.0 
(5.0-9.0)
4.0 
(3.5-5.0)
8.0 
(7.0-9.0)
Sex (M), n (%) 119 
(59.8)
41 
(68.3)
78 
(56.1)
115 
(59.9)
42 
(68.9)
73 
(55.7)
Wheal size (mm)†, ‡ 2.0 
(2.0-3.0)
2.0 
(2.0-3.0)
2.0 
(2.0-3.0)
0.46 2.0 
(2.0-3.0)
2.0 
(2.0-3.0)
2.0 
(2.0-3.0)
0.19
Distribution of wheal 
size, n (%)‡
0.35 0.09
1≤ <1.5 14 
(7.0)
1 
(1.7)
13 
(9.4)
15 
(7.8)
1 
(1.6)
14 
(10.7)
1.5≤ <2 19 
(9.5)
6 
(10.0)
13 
(9.4)
18 
(9.4)
6 
(9.8)
12 
(9.2)
≥2 166 
(83.4)
53 
(88.3)
113 
(81.3)
159 
(82.8)
54 
(88.5)
105 
(80.2)
Wheal size (mm)†, § 2.0 
(0.0-4.0)
0.0 
(0.0-3.4)
2.0 
(0.0-4.0)
<0.05‖ 0.0 
(0.0-2.0)
0.0 
(0.0-0.0)
0.0 
(0.0-2.0)
0.02‖
Distribution of wheal 
size, n (%)§
0.22 0.00#
<2 mm 98 
(49.2)
36 
(60.0)
62 
(44.6)
141 
(73.4)
51 
(83.6)
90 
(68.7)
2 mm≤ <3 mm 21 
(10.6)
4 
(6.7)
17 
(12.2)
17 
(8.9)
2 
(3.3)
15 
(11.5)
3 mm≤ <4 mm 27 
(13.6)
8 
(13.3)
19 
(13.7)
9 
(4.7)
6 
(9.8)
3 
(2.3)
≥4 mm 53 
(26.6)
12 
(20.0)
41 
(29.5)
25 
(13.0)
2 
(3.3)
23 
(17.6)
sIgE (kU/L), n (%) 0.02# <0.01#
<0.35 90 
(45.2)
36 
(60.0)
54 
(38.8)
118 
(61.5)
48 
(78.7)
70 
(53.4)
0.35-95% PPV 18 
(9.0)
4 
(6.7)
14 
(10.1)
51 
(26.6)
9 
(14.8)
42 
(32.1)
≥95% PPV¶ 91 
(45.7)
20 
(33.3)
71 
(51.1)
23 
(12.0)
4 
(6.6)
19 
(14.5)
†Median (interquartile range).
‡Mean wheal diameter for histamine.
§Mean wheal diameter for allergen.
¶The 95% positive predictive value for positive oral challenge test ≤2 years was defi ned as egg white ≥2 kU/L, and cow’s milk ≥5 kU/L.
‖Mann Whitney U test, P < 0.05.
#Chi-square test, P < 0.05.
tive predictive value were observed between SPT and
sIgE. As to CW, 51.4% for sensitivity, 92.4% for speci-
ficity, 80.9% for positive predictive value, and 75.2% for
negative predictive value were observed. Substantial
agreement was observed as to EW (κ = 0.69),
whereas moderate agreement was observed in CM (κ
= 0.47).
Differences in kappa values between the 2 age
groups were not significant as to EW and CM (EW, κ
= 0.75 vs. 0.66, P = 0.37; CM, κ = 0.26 vs. 0.47, P =
0.58) (Table 3).
DISTRIBUTION OF MEAN WHEAL DIAMETERS
IN EW AND CM ACCORDING TO AGE IN
MONTHS
The mean wheal diameter in EW was not positively
correlated with age (γ = 0.134, P = 0.06); however, af-
ter adjustment for sIgE, it was weakly positively cor-
related with age (γ = 0.139, P = 0.04). On the contrary,
the mean wheal diameter in CM was weakly posi-
tively correlated with age (γ = 0.147, P = 0.04), but
was not significant after adjustment for sIgE (γ =
0.126, P = 0.08). The mean wheal diameters in EW
and CM were evenly distributed, and did not show in-
creasing trends regardless of age in months (Ptrend =
0.13 and P trend = 0.06, respectively) (Fig. 2).
Agreement between SPT and Specific IgE
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Table　2　Kappa statistics between mean wheal diameter of SPTs and those of sIgE for egg white and cow milk, and compari-
son of Kappa statistics between the age groups of <6 months and ≥6 months with mild-to-moderate atopic dermatitis
SPT†
sIgE‡ Observed 
agreement Kappa (95% CI) P
§
Positive (%) Negative (%)
Egg white Total, n = 199 Positive
Negative
75 (37.7)
34 (17.1)
 5 (2.5)
 85 (42.7)
0.80 0.62 (0.51-0.72)
≥6 mo, n = 139 Positive
Negative
56 (40.3)
29 (20.9)
 4 (2.9)
 50 (36.0)
0.76 0.54 (0.41-0.67) 0.02
<6 mo, n = 60 Positive
Negative
19 (31.7)
5 (8.3)
 1 (1.7)
 35 (58.3)
0.90 0.79 (0.62-0.95)
Cow milk Total, n = 192 Positive
Negative
27 (14.1)
47 (24.5)
 7 (3.7)
111 (57.8)
0.72 0.34 (0.21-0.47)
≥6 mo, n = 131 Positive
Negative
23 (17.6)
38 (29.0)
 3 (2.3)
 67 (51.1)
0.69 0.35 (0.21-0.48) 0.60
<6 mo, n = 61 Positive
Negative
4 (6.6)
 9 (14.8)
 4 (6.6)
 44 (72.1)
0.79  0.26 (-0.03-0.55)
†Positivity defi ned as 3 mm ≥ negative control.
‡Positivity defi ned as ≥0.35 kU/L.
§Test for equal kappa statistics between the age groups of <6 and ≥6 months.
Table　3　Kappa statistics between the allergen to histamine ratio of SPT and sIgE for egg white and cow’s milk, and compari-
son of the Kappa statistics between the age groups of <6 months and ≥6 months with mild-to-moderate atopic dermatitis
SPT†
sIgE‡ Observed 
agreement Kappa (95% CI) P
§
Positive (%) Negative (%)
Egg white Total, n = 199 Positive
Negative
84 (42.2)
25 (12.6)
 6 (3.0)
 84 (42.2)
0.84 0.69 (0.59-0.79)
≥6 mo, n = 139 Positive
Negative
65 (46.8)
20 (14.4)
 4 (2.9)
 50 (36.0)
0.83 0.66 (0.53-0.78) 0.37
<6 mo, n = 60 Positive
Negative
19 (31.7)
5 (8.3)
 2 (3.3)
 34 (56.7)
0.88 0.75 (0.58-0.92)
Cow milk Total, n = 192 Positive
Negative
38 (19.8)
36 (18.8)
 9 (4.7)
109 (56.8)
0.77 0.47 (0.34-0.60)
≥6 mo, n = 131 Positive
Negative
33 (25.2)
28 (21.4)
 6 (4.6)
 64 (48.9)
0.74 0.47 (0.32-0.61) 0.58
<6 mo, n = 61 Positive
Negative
5 (8.2)
 8 (13.1)
 3 (4.9)
 45 (73.8)
0.82 0.26 (0.08-0.67)
†Positivity defi ned as an A/H ratio of ≥1.
‡Positivity defi ned as ≥0.35 kU/L.
§Test for equal kappa statistics between the age groups of <6 and ≥6 months.
DISCUSSION
In this study, we evaluated agreements between SPT
and sIgE for EW and CM allergens in young infants
with mild-to-moderate AD. A previous study reported
that results of SPT do not agree well with those of
sIgE in young infants.14,15 However, our results
showed that 1) the results of SPTs for food allergens
agreed well with those of sIgE in young infants with
AD, and 2) the mean wheal diameters for EW and
CM were evenly distributed, and did not show in-
creasing trends regardless of age in months. To the
best of our knowledge, this is the first study to inves-
tigate the distribution of wheal response to food aller-
gens according to age in months in young infants
with mild-to-moderate AD.
AD AND EARLY SENSITIZATION AS PREDIC-
TORS OF LATER ASTHMA
The etiologies of allergic diseases, including asthma,
have been considered multifactorial. Numerous fac-
tors have been investigated as potential predictors for
the development and severity of asthma.4-6,18 Never-
theless there is no biomarker to clearly predict subse-
Yang HJ et al.
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Fig.　2　Restricted cubic spline graph showing no trend (P = 0.13 and P = 0.06, respectively) in the dis-
tribution of skin reactivity to EW and CM according to age in months. (A) Mean wheal diameters for EW 
were evenly distributed regardless of age (γ = 0.134, P = 0.06); however, after adjustment for sIgE, they 
were weakly positively correlated with age (γ = 0.139, P = 0.04). On the contrary, (B) Mean wheal diame-
ters for CM were weakly positively correlated with age (γ = 0.147, P = 0.04), but were not statistically sig-
nifi cant after adjustment for sIgE (γ = 0.126, P = 0.08).
A B
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quent development of allergic disease.
Numerous longitudinal observational studies have
proved the natural course of allergic disease from
early sensitization and eczema in infancy to later
childhood (i.e., allergic march). Early sensitization to
foods4,19 or inhalant allergens,20 and AD have been
emphasized as a strong predictors of later allergic
diseases. In particular, atopic eczema with food sensi-
tization in early life, rather than non-atopic eczema,
was strongly associated with increased risk of later
asthma.4,18
Although there is the possibility that early food
sensitization is confounded by early eczema, early
food sensitization appears to be an independent risk
factor for later development of asthma and allergic
rhinitis regardless of AD.4,5 Moreover, early atopic
sensitization in young infants with AD appears to be
associated with the risk of severe exacerbations of
early asthma.3 To date, there have been few effective
preventive strategies for the development of asthma,
and it has been emphasized that early identification
and intervention are the best ways to reduce associ-
ated morbidities and socioeconomic burden.21 There-
fore, early identification of children at high risk of
later asthma has numerous clinical implications.
However, atopic eczema and non-atopic eczema could
not differentiated by physical examination alone.
Thus, detection of atopic sensitization in young in-
fants with AD is essential in clinical practice. For
these reasons, early food sensitization andor AD
would be a target for further interventional studies,
and therefore atopic sensitization should be identified
in young infants with AD.
AGREEMENT BETWEEN SPT AND sIgE FOR
FOOD ALLERGEN
Of an unselected cohort of 353 infants (age 2 years)
from The Prevention of Allergy among Children in
Trondheim (PACT) study, 15.6% were sensitized to
food allergens and 34.3% had AD. That study reported
weak agreement between SPT and sIgE for both EW
(κ = 0.37) and CM (κ = 0.19); therefore, these 2 tests
should not be used interchangeably, but complemen-
tarily, for the detection of atopic sensitization.14 How-
ever, our results did not support the results of The
PACT study but rather showed that STP and sIgE
agreed well with each other. This discordance might
be due to the different study populations and low sen-
sitization rates in The PACT study (e.g., EW, 11.4%;
CM, 5.1%) compared to our higher sensitization rates
for both EW (57.3%) and CM (42.2%).
SKIN REACTIVITY IN YOUNG INFANTS
Contrary to sIgE levels, which represent the pres-
Agreement between SPT and Specific IgE
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ence of circulating allergen-specific IgE antibody,
SPT represents the overall response according to the
levels of histamine and other mediators (e.g.,
prostaglandin, leukotrienes, and platelet-activating
factor) released from mast cells activated by the inter-
action between allergen and sIgE antibodies on the
cell surface. Therefore, it has been suggested that
SPT should not be interchangeably used with sIgE
because circulating IgE is not equivalent to cell-
bound histamine-releasing active mediators.22 How-
ever Hill et al.23 have reported that although the re-
sponses of mast cells in the skin to allergens are
lower in younger infants, the diagnostic accuracy of
SPT is either similar or more sensitive than sIgE
measurement, and SPT for food allergens is more
clinically relevant. Skin reactions vary with age, and
infants may react predominantly with large erythema-
tous flares and small wheals. However, since large
wheals are observed even in young infants, skin tests
are useful for the diagnosis of allergic diseases in this
population.
SAFETY CONCERNS ABOUT THE USE OF SPT
IN YOUNG INFANTS
Despite the usefulness and safety of SPT, concerns
about severe systemic reactions such as anaphylaxis
seem to be a reason for avoiding SPT in young in-
fants. Although we did not find systemic reactions in
the subjects included in the current study, the overall
incidence of adverse reactions is approximately 0.04%
in children,24 and deaths (<0.02%) by SPT with fresh
foods have been reported.25 Because infants cannot
effectively complain of the early symptoms of a sys-
temic reaction,26 physicians should be aware of the
possibility of fatal systemic reactions, particularly in
infants who have had severe reactions, and should
carefully perform the test and observe the results in
an office fully equipped with emergency kits.
STRENGTHS AND LIMITATIONS
The major strengths of this study are as follows: 1)
Since SPT and sIgE measurement were performed at
the same date, and SPT was performed by the same
trained technician and interpreted by the same physi-
cian, our study provided more consistent results than
multicenter studies. 2) The sample size was large to
analyze the agreement due to the high sensitization
rate. 3) Infants with severe AD were excluded to
avoid any misinterpretation that could originate from
poor or severe responsse of inflamed skin, even look-
ing clear.
However, this study also has inherent limitations
due to its retrospective design. The interferences of
drugs, such as antihistamines or local corticosteroids,
as well as systemic illness before SPT, may not been
completely excluded. For example, 33 of the 233 sub-
jects (14.2%) tested for EW were excluded because of
poor skin responses to histamine. However, we did
our best to reduce the interference by excluding sub-
jects with poor skin responses to histamine. Repeated
comparison between SPT and sIgE are necessary to
evaluate the maturity of skin response by age. How-
ever, even in a prospective study, monthly measure-
ments in young infants may be impossible because of
ethical issues.
Food allergens have been reported to be an impor-
tant risk factor for the development and exacerbation
of AD. The prevalence of food allergy (FA) is known
to be up to 5%-6% in infancy,7,27 and about 35% of chil-
dren with moderate-to-severe atopic dermatitis (AD)
have FA as a trigger.28 Therefore, detection of causa-
tive food allergens in AD coincident with FA would
be important in clinical practice. In our study, 26.6%
(52192) of the patients were clinically diagnosed
with milk allergy, and 31.2% (62199) with egg al-
lergy. This low prevalence of FA may be due to the
retrospective design and younger subjects.
Taken together, although the detection rate of food
sensitization is lower in SPT, the results of SPT for
food allergens agreed well with those of sIgE in
young infants with AD. Moreover, skin responses to
food allergens were evenly distributed regardless of
age. These findings suggest that SPT can be used
along with sIgE to detect food sensitization in young
infant with AD and may predict the risk of later
asthma in order to prevent disease progression.
In conclusion, our findings may provide the ration-
ale for the use of SPT in young infants with AD in
both clinical and research settings, and may deserve
future research into better prediction methods for al-
lergic diseases.
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